期刊文献+

Endostatin抑制小鼠膀胱癌的作用机理研究 被引量:5

Mechanism of endostatin inhibiting growth of mouse bladder cancer
原文传递
导出
摘要 目的 探讨endostatin抑制膀胱癌生长的作用机理。 方法 体外培养小鼠膀胱移行细胞癌T739细胞 ,以endostatin 10 μg/ml处理 ,观察细胞增殖、凋亡情况 ;endostatin 2 0mg·kg-1·d-1皮下注射T739膀胱癌荷瘤小鼠 ,观察肿瘤细胞增殖、凋亡指数及Fas与Bcl 2在肿瘤细胞中的表达。 结果 体外实验显示 ,对照组及endostatin组T739细胞增殖指数分别为 (5 8.3± 9.3) %、(5 9.4± 8.6 ) % ,凋亡指数分别为 (7.2± 1.1) %、(7.5± 1.0 ) % ,差异均无显著性意义 (P >0 .0 5 ) ;动物实验显示 ,对照组及endostatin组肿瘤细胞增殖指数分别为 (5 9.1± 6 .7) %、(5 8.6± 6 .3) % ,差异无显著性意义 (P >0 .0 5 ) ;对照组凋亡指数为 (1.9± 0 .4 ) % ,治疗组为 (9.7± 0 .9) % ,差异有显著性意义 (P <0 .0 1) ;endo statin组肿瘤细胞Fas表达明显增加 ,对照组及治疗组肿瘤细胞均无明显Bcl 2表达。 结论 endo statin可能通过抑制血管形成导致组织缺氧 ,上调Fas表达诱导肿瘤细胞凋亡 ,从而抑制小鼠膀胱癌生长。 Objective To investigate the mechanism of endostatin inhibiting the growth of mouse T739 bladder cancer. Methods Treated with endostatin 10 μg/ml,T739 cells were evaluated by proliferating cell nuclear antigen(PCNA) and TUNEL in vitro.T739 cell-bearing mice were administrated with endostatin 20 mg·kg -1 ·d -1 .12 days later,histological sections of tumors were analyzed for PCNA and TUNEL,immunohistochemical staining of Fas and Bcl-2 were monitored by confocal laser scanning microscope. Results In vitro,the proliferation index (PI) of T739 cells was(58.3±9.3)% in group of control,(59.4±8.6)% in group of endostatin( P >0.05), and the apoptotic index (AI) was (7.2±1.1)% in group of control,(7.5±1.0)% in group of endostatin( P >0.05).In vivo,the PI of mouse tumor cells was(58.6±6.3)% in group of endostatin,(59.1±6.7)% in the control( P >0.05).The AI of tumor cells was(9.7±0.9)% in mice treated with endostatin compared to that (1.9±0.4)% in the group of control ( P <0.01).The expression of Fas in tumor cell membrane increased in mice treated with endostatin.There was no difference of Bcl-2 expression between the tumor cells in mice treated with endostatin and that in the control. Conclusions Inhibiting angiogenesis of tumor,endostatin may induce ischemia and hypoxygen in tumor tissue,which result in Fas expression and signaling apoptotic cell death,thus endostatin can suppress growth of bladder cancer in mice.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2004年第6期365-367,共3页 Chinese Journal of Urology
基金 国家自然科学基金资助 (3 980 0 198)
关键词 Endostatin抑制 小鼠 膀胱癌 肿瘤细胞 Bladder neoplasms Endostatin Animals,laboratory
  • 相关文献

参考文献6

  • 1Ren B,Hoti N,Rabasseda X,et al.The antiangiogenic and therapeutic implications of endostatin.Methods Find Exp Clin Pharmacol,2003,25:215-224.
  • 2O' Reilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth.Cell,1997,88:277-285.
  • 3Kunz M,Ibrahim SM.Molecular responses to hypoxia in tumor cells.Mol Cancer,2003,2:23.
  • 4Nagata S.Apoptosis by death factor.Cell,1997,88:355-365.
  • 5Volm M,Mattern J,Koomagi R.Inverse correlation between apoptotic(Fas ligand,caspase-3)and angiogenic factors(VEGF,microvessel density)in squamous cell lung carcinomas.Anticancer Res,1999,19:1669-1671.
  • 6王亮 金锡御 宋波.血管形成抑制剂endostatin对小鼠膀胱癌的抑制作用[J].中华实验外科杂志,2001,18:92-93.

同被引文献62

  • 1李根丛,聂明明,杨甲梅,苏长青,孙立臣,钱炎珍,Jonathan Sham,方国恩,吴孟超,钱其军.基因-病毒治疗系统CNHK300-murine endostatin治疗肝癌的实验研究[J].中华医学杂志,2004,84(11):943-948. 被引量:5
  • 2王贵齐,王耐勤,刘彤,徐光炜,董志伟.血管内皮生长因子抗体对实验性肿瘤的抑制作用[J].中华肿瘤杂志,1997,19(3):163-166. 被引量:18
  • 3Rege TA, Fears CY, Gladson CL. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy, Neuro Oncol, 2005, 7 (2): 106
  • 4Dkhissi F, Lu H, Sofia C et al. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer ceils [J]. Hum Gene Ther, 2003, 14:997
  • 5Thomas JP, Arzoomanian RZ , Alberti D et al. Phase Ⅰ pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors [J]. J Clin Oncol , 2003 , 21 : 223
  • 6Dhanabal M, Volk R, Ramchandran R et al. Cloning , expression and in vitro activity of human endostatin [ J]. Biochem Biophys Res Commun, 1999, 258 (2): 345
  • 7Paley PJ. Angiogenesis in ovarian cancer: molecular pathology and therapeutic strategies [J]. Curt Oncol Rep, 2002, 4:165
  • 8Isayeva T, Ren C, Ponnazhagan S. Intraperitoneal gene therapy by rAAV provides long - term survival against epithelial ovarian cancer independently of survivin pathway [ J ]. Gene Ther, 2007, 14 (2) : 138
  • 9Boehm T, Folkman J, Browder T et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J]. Nature, 1997, 390 (6658): 404
  • 10Ren B, Wang Y, Ndebele K et al. Multiple signaling is involved in endostatin -mediated apoptosis in ECV 304 endothelial cells [J]. Front Biosci, 2005, 10:1089

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部